Literature DB >> 9870642

p53 tumor suppressor gene in acoustic neuromas.

K Monoh1, K Ishikawa, N Yasui, K Mineura, H Andoh, K Togawa.   

Abstract

Alterations of the p53 tumor suppressor gene in 21 cases with acoustic neuroma were investigated by polymerase chain reaction-restriction fragment polymorphism (PCR-RFLP) and single strand conformation polymorphism (PCR-SSCP). Neither mutation nor deletion was found. In 13 informative cases, no loss of heterozygosity (LOH) was confirmed. Thus our results further substantiate the scant contribution of p53 gene tumorigenesis and cell proliferation to acoustic neuromas.

Entities:  

Mesh:

Year:  1998        PMID: 9870642     DOI: 10.1080/00016489850182288

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  4 in total

1.  Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.

Authors:  Hongsai Chen; He Huang; Jingjing Zhao; Zhigang Wang; Mengling Chang; Lu Xue; Weidong Zhu; Yongchuan Chai; Gen Li; Zhaoyan Wang; Hao Wu
Journal:  J Neurooncol       Date:  2019-05-02       Impact factor: 4.130

2.  Clinical and Histologic Parameters Correlated with Facial Nerve Function After Vestibular Schwannoma Surgery.

Authors:  Vincent Couloigner; Elena Gervaz; Michel Kalamarides; Evelyne Ferrary; Alain Rey; Olivier Sterkers; Dominique Hénin
Journal:  Skull Base       Date:  2003-02

3.  p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during in vitro tumor progression.

Authors:  Xiye Li; Hongsai Chen; Lu Xue; Xiuhong Pang; Xiaoman Zhang; Zhengjie Zhu; Weidong Zhu; Zhaoyan Wang; Hao Wu
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

Review 4.  The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature.

Authors:  Mark C Dougherty; Seiji B Shibata; Marlan R Hansen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.